🚀 Calling experts in #ContractResearchOrganisations, #ClinicalTrials and #Antipsychotic #DrugDevelopment! 🚀
Supported by Innovate UK Innovate UK ICURe , Keele University researchers are conducting market discovery for iSWITCHED, a digital tool that can transform antipsychotic switching in drug development trials. Such trials often require switching from current treatments to investigational drugs. Our tool aims to streamline protocols, improve patient outcomes, minimise dropout rates, and generate real-world evidence to support regulatory success.
Why Participate?
📊 Drive Innovation: Shape development of a tool designed to address trial inefficiencies.
⏱️ Quick & Actionable: Contribute your expertise in 4 minutes to refine a solution for unmet needs in clinical trials.
🌐 Stay Ahead: Be part of a forward-thinking approach to enhancing trial efficiency and outcomes.
👉 Take the Survey Now: https://lnkd.in/g9XHhfc9
👥 Share this survey and help us create smarter solutions for clinical trials
#InnovateUK #ICURe #SevereMentalIllness #ClinicalTrials #DrugDevelopment #DigitalHealth #PharmaInnovation #CROs #RealWorldEvidence #Antipsychotics #ClinicalTrialEfficiency #TrialOptimisation #ResearchAndDevelopment #HealthTechSolutions #MedTech #KeeleUniversity #NIHR
A digital antipsychotic switching tool can streamline drug switching in trials by providing real-time data, tracking patient responses, and ensuring personalized dosing adjustments. This improves patient outcomes by minimizing adverse effects and optimizing efficacy, while supporting regulatory success by ensuring consistent monitoring, accurate data collection, and compliance with trial protocols.
Dear Amit, Thanks ! Would be super useful to gain further insights from you: https://research.typeform.com/to/ZybgUNnM?typeform-source=lnkd.in
- Badges
- Science topic
- Similar topics
- Chemistry
- Pharmacology
- Medical Pharmacology
- Clinical Pharmacology